Morbidity and Mortality Weekly Report

Displaying 1 - 19 of 19
Link-Gelles, R., Chickery, S., Webber, A., Ong, T. C., Rowley, E. A. K., DeSilva, M. B., Dascomb, K., Irving, S. A., Klein, N. P., Grannis, S. J., Barron, M. A., Reese, S. E., McEvoy, C., Sheffield, T., Naleway, A. L., Zerbo, O., Rogerson, C., Self, W. H., Zhu, Y., … Zepeski, A. (2025). Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025. MMWR. Morbidity and Mortality Weekly Report, 74(6), 73–82. https://doi.org/10.15585/mmwr.mm7406a1
Publication Date
Papa, A., Barile, J. P., Jia, H., Thompson, W. W., & Guerin, R. J. (2025). Gaps in Mental Health Care–Seeking Among Health Care Providers During the COVID-19 Pandemic — United States, September 2022–May 2023. MMWR. Morbidity and Mortality Weekly Report, 74(2), 19–25. https://doi.org/10.15585/mmwr.mm7402a1
Publication Date
Zucker, J., Caplan, A. S., Gunaratne, S. H., Gallitano, S. M., Zampella, J. G., Otto, C., Sally, R., Chaturvedi, S., O’Brien, B., Todd, G. C., Anand, P., Quilter, L. A. S., Smith, D. J., Chiller, T., Lockhart, S. R., Lyman, M., Pathela, P., & Gold, J. A. W. (2024). Notes from the Field: Trichophyton mentagrophytes Genotype VII — New York City, April–July 2024. MMWR. Morbidity and Mortality Weekly Report, 73(43), 985–988. https://doi.org/10.15585/mmwr.mm7343a5
Publication Date
Smith-Jeffcoat, S. E., Mellis, A. M., Grijalva, C. G., Talbot, H. K., Schmitz, J., Lutrick, K., Ellingson, K. D., Stockwell, M. S., McLaren, S. H., Nguyen, H. Q., Rao, S., Asturias, E. J., Davis-Gardner, M. E., Suthar, M. S., Kirking, H. L., Rolfes, M. A., Biddle, J. E., Zhu, Y., … Ledezma, K. (2024). SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance — Respiratory Virus Transmission Network, November 2022–May 2023. MMWR. Morbidity and Mortality Weekly Report, 73(16), 365–371. https://doi.org/10.15585/mmwr.mm7316a2
Publication Date
Zambrano, L. D., Newhams, M. M., Simeone, R. M., Payne, A. B., Wu, M., Orzel-Lockwood, A. O., Halasa, N. B., Calixte, J. M., Pannaraj, P. S., Mongkolrattanothai, K., Boom, J. A., Sahni, L. C., Kamidani, S., Chiotos, K., Cameron, M. A., Maddux, A. B., Irby, K., Schuster, J. E., … Mack, E. H. (2024). Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023. MMWR. Morbidity and Mortality Weekly Report, 73(15), 330–338. https://doi.org/10.15585/mmwr.mm7315a2
Publication Date
Link-Gelles, R., Rowley, E. A. K., DeSilva, M. B., Dascomb, K., Irving, S. A., Klein, N. P., Grannis, S. J., Ong, T. C., Weber, Z. A., Fleming-Dutra, K. E., McEvoy, C. E., Akinsete, O., Bride, D., Sheffield, T., Naleway, A. L., Zerbo, O., Fireman, B., Hansen, J., Goddard, K., … Payne, A. B. (2024). Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions — VISION Network, September 2023–February 2024. MMWR. Morbidity and Mortality Weekly Report, 73(12), 271–276. https://doi.org/10.15585/mmwr.mm7312a5
Publication Date
DeCuir, J., Payne, A. B., Self, W. H., Rowley, E. A. K., Dascomb, K., DeSilva, M. B., Irving, S. A., Grannis, S. J., Ong, T. C., Klein, N. P., Weber, Z. A., Reese, S. E., Ball, S. W., Barron, M. A., Naleway, A. L., Dixon, B. E., Essien, I., Bride, D., … Natarajan, K. (2024). Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024. MMWR. Morbidity and Mortality Weekly Report, 73(8), 180–188. https://doi.org/10.15585/mmwr.mm7308a5
Publication Date
Link-Gelles, R., Ciesla, A. A., Rowley, E. A. K., Klein, N. P., Naleway, A. L., Payne, A. B., Kharbanda, A., Natarajan, K., DeSilva, M. B., Dascomb, K., Irving, S. A., Zerbo, O., Reese, S. E., Wiegand, R. E., Najdowski, M., Ong, T. C., Rao, S., Stockwell, M. S., Stephens, A., … Fleming-Dutra, K. E. (2023). Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023. MMWR. Morbidity and Mortality Weekly Report, 72(33), 886–892. https://doi.org/10.15585/mmwr.mm7233a2
Publication Date
Link-Gelles, R., Weber, Z. A., Reese, S. E., Payne, A. B., Gaglani, M., Adams, K., Kharbanda, A. B., Natarajan, K., DeSilva, M. B., Dascomb, K., Irving, S. A., Klein, N. P., Grannis, S. J., Ong, T. C., Embi, P. J., Dunne, M. M., Dickerson, M., McEvoy, C., Arndorfer, J., … Tenforde, M. W. (2023). Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023. MMWR. Morbidity and Mortality Weekly Report, 72(21), 579–588. https://doi.org/10.15585/mmwr.mm7221a3
Publication Date
Tenforde, M. W., Weber, Z. A., Natarajan, K., Klein, N. P., Kharbanda, A. B., Stenehjem, E., Embi, P. J., Reese, S. E., Naleway, A. L., Grannis, S. J., DeSilva, M. B., Ong, T. C., Gaglani, M., Han, J., Dickerson, M., Fireman, B., Dascomb, K., Irving, S. A., Vazquez-Benitez, G., … Link-Gelles, R. (2022). Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022. MMWR. Morbidity and Mortality Weekly Report, 71(5152), 1616–1624. https://doi.org/10.15585/mmwr.mm715152e1
Publication Date
Miller, M. J., Cash-Goldwasser, S., Marx, G. E., Schrodt, C. A., Kimball, A., Padgett, K., Noe, R. S., McCormick, D. W., Wong, J. M., Labuda, S. M., Borah, B. F., Zulu, I., Asif, A., Kaur, G., McNicholl, J. M., Kourtis, A., Tadros, A., Reagan-Steiner, S., Ritter, J. M., … Pottinger, P. (2022). Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022. MMWR. Morbidity and Mortality Weekly Report, 71(44), 1412–1417. https://doi.org/10.15585/mmwr.mm7144e1
Publication Date

Britton, A., Embi, P. J., Levy, M. E., Gaglani, M., DeSilva, M. B., Dixon, B. E., Dascomb, K., Patel, P., Schrader, K. E., Klein, N. P., Ong, T. C., Natarajan, K., Hartmann, E., Kharbanda, A. B., Irving, S. A., Dickerson, M., Dunne, M. M., Raiyani, C., Grannis, S. J., Stenehjem, E., … Tenforde, M. W. (2022). Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022. MMWR. Morbidity and mortality weekly report, 71(42), 1335–1342. https://doi.org/10.15585/mmwr.mm7142a4

Publication Date
Britton, A., Embi, P. J., Levy, M. E., Gaglani, M., DeSilva, M. B., Dixon, B. E., Dascomb, K., Patel, P., Schrader, K. E., Klein, N. P., Ong, T. C., Natarajan, K., Hartmann, E., Kharbanda, A. B., Irving, S. A., Dickerson, M., Dunne, M. M., Raiyani, C., Grannis, S. J., … Tenforde, M. W. (2022). Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022. MMWR. Morbidity and Mortality Weekly Report, 71(42), 1335–1342. https://doi.org/10.15585/mmwr.mm7142a4
Publication Date
Link-Gelles, R., Lutterloh, E., Schnabel Ruppert, P., Backenson, P. B., St. George, K., Rosenberg, E. S., Anderson, B. J., Fuschino, M., Popowich, M., Punjabi, C., Souto, M., McKay, K., Rulli, S., Insaf, T., Hill, D., Kumar, J., Gelman, I., Jorba, J., Ng, T. F. F., … Yang, V. Q. (2022). Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater — New York, June–August 2022. MMWR. Morbidity and Mortality Weekly Report, 71(33), 1065–1068. https://doi.org/10.15585/mmwr.mm7133e2
Publication Date

Link-Gelles, R., Levy, M. E., Gaglani, M., Irving, S. A., Stockwell, M., Dascomb, K., DeSilva, M. B., Reese, S. E., Liao, I. C., Ong, T. C., Grannis, S. J., McEvoy, C., Patel, P., Klein, N. P., Hartmann, E., Stenehjem, E., Natarajan, K., Naleway, A. L., Murthy, K., Rao, S., … Tenforde, M. W. (2022). Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022. MMWR. Morbidity and mortality weekly report, 71(29), 931–939. https://doi.org/10.15585/mmwr.mm7129e1

Publication Date

Natarajan, K., Prasad, N., Dascomb, K., Irving, S. A., Yang, D. H., Gaglani, M., Klein, N. P., DeSilva, M. B., Ong, T. C., Grannis, S. J., Stenehjem, E., Link-Gelles, R., Rowley, E. A., Naleway, A. L., Han, J., Raiyani, C., Benitez, G. V., Rao, S., Lewis, N., Fadel, W. F., … Dixon, B. E. (2022). Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022. MMWR. Morbidity and mortality weekly report, 71(13), 495–502. https://doi.org/10.15585/mmwr.mm7113e2

Publication Date
Klein, N. P., Stockwell, M. S., Demarco, M., Gaglani, M., Kharbanda, A. B., Irving, S. A., Rao, S., Grannis, S. J., Dascomb, K., Murthy, K., Rowley, E. A., Dalton, A. F., DeSilva, M. B., Dixon, B. E., Natarajan, K., Stenehjem, E., Naleway, A. L., Lewis, N., Ong, T. C., … Verani, J. R. (2022). Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022. MMWR. Morbidity and Mortality Weekly Report, 71(9), 352–358. https://doi.org/10.15585/mmwr.mm7109e3
Publication Date

Ferdinands, J. M., Rao, S., Dixon, B. E., Mitchell, P. K., DeSilva, M. B., Irving, S. A., Lewis, N., Natarajan, K., Stenehjem, E., Grannis, S. J., Han, J., McEvoy, C., Ong, T. C., Naleway, A. L., Reese, S. E., Embi, P. J., Dascomb, K., Klein, N. P., Griggs, E. P., Konatham, D., … Fireman, B. (2022). Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. MMWR. Morbidity and mortality weekly report, 71(7), 255–263. https://doi.org/10.15585/mmwr.mm7107e2

Publication Date
Thompson, M. G., Natarajan, K., Irving, S. A., Rowley, E. A., Griggs, E. P., Gaglani, M., Klein, N. P., Grannis, S. J., DeSilva, M. B., Stenehjem, E., Reese, S. E., Dickerson, M., Naleway, A. L., Han, J., Konatham, D., McEvoy, C., Rao, S., Dixon, B. E., Dascomb, K., … Ong, T. C. (2022). Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022. MMWR. Morbidity and Mortality Weekly Report, 71(4), 139–145. https://doi.org/10.15585/mmwr.mm7104e3
Publication Date